Pharmacology Flashcards
1
Q
Michaelis Menten kinetics
- Km
- Vmax
- curve
A
- related to affinity of enzyme for substrate; on x axis
- directly proportional to enzyme concentration; on y axis
- hyperbolic, sigmoid
2
Q
Lineweaver-burk plot
- vmax
- Km
- competitive inhibitors
- noncompetitive inhibitors
A
- y intercept, higher the intercept lower the vmax
- x intercept, further to the right the greater the Km and lower the affinity
- cross each other, and increased Km
- do not cross each other
3
Q
Pharmacodynamics
- competitive inhibitor, reversible: resemble substrate, overcome by [s], bind active site, effect on vmax, effect on Km, pharmacodynamics
- competitive inhibitors, irreversible: resemble substrate, overcome by [s], bind active site, effect on vmax, effect on Km, pharmacodynamics
- noncompetitive inhibitors: resemble substrate, overcome by [s], bind active site, effect on vmax, effect on Km, pharmacodynamics
A
- resemble substrate, overcome by increase in [substrate], bind active site, do not change vmax, increase Km, decrease potency
- resemble substrate, not overcomed by [substrate], bind active site, decrease vmax, Km unchanged, decreased efficacy of pharmacodynamics
- do not resemble substrate, not overcome by [substrate], do not bind active site, decrease Vmax, do not change Km, decrease efficacy
4
Q
Pharmacokinetics
- bioavailability
- volume of distribution
- clearance
- half life
- dosage calculation
A
- fraction of administered drug reaching systemic circulation
- volume of total amount of drug in body relative to plasma concentration
- volume of plasma cleared of drug per unit time; rate of elimination of drug // plasma drug concentration
- the time required to change the amount of drug in body by 1/2 during elimination, 1-50, 2-25, 3-12.5, 4-6.25
5
Q
Types of drug interactions
- additive
- permissive
- synergistic
- tachyohylactic
A
- effect of substance A and B together is equal to sum of individual effects
- presence of substance A is required for full effect of substance B
- effect of substance A and B together is greater that the sum of their individual
- acute decrease in response to drug after initial/repeated administration
6
Q
Elimination of drugs
- zero order
- first order
A
- rate of elimination is constant
- rate of elimination is proportional to drug concentration
7
Q
Urine pH and drug elimination
- what happens
A
- ionized species are trapped in urine and cleared while neutral forms can be reabsorbed
8
Q
Drug metabolism
- phase I
- phase II
A
- reduction, oxidation hydrolysis w/ cytochrome p450
- conjugation, usually yields very polar inactive metabolites
9
Q
Efficacy vs potency
- efficacy
- potency
A
- max effect drug can produce, represented by increase in vmax
- amount of drug needed for given effect, represented by middle of x
10
Q
Therapeutic index
- what is it
- equation
- therapeutic window
A
- measurement of drug safety; high is safe and low needs to be monitored
- median toxic dose // median effective dose
- dosage range that can safely and effectively treat disease
11
Q
Autonomic receptors
- parasympathetic
- sympathetic
A
- Ach on nicotinic, and Ach on muscarinic
- Ach on nicotinic, and Epi on alpha/beta
12
Q
Acetylcholine receptors
- nicotinic MOA
- nicotinic subtypes
- muscarinic MOA
- muscarinic location
A
- ligand gated Na/K channels
- Nn found in autonomics and Nm found in NMJ
- gPCR -> act through second messengers
- muscle , brain, exocrine gland, sweat gland
13
Q
G-protein linked second messengers sympathetic
- alpha 1
- alpha 2
- beta 1
- beta 2
- beta 3
A
- q; increase vascular SM contractions, increase pupillary dilator contraction, increase intestinal and bladder sphincter contraction
- i; decrease sympathetic outflow (epi will bind back on pre-synaptic nerve to modulate release of epi), decrease insulin release, decrease lipolysis, increase platelet aggregation, decrease AQH production
- s; increase heart rate, contractility, renin release, lipolysis
- s; vasodilation, bronchodilation, increase lipolysis, increase insulin release, increase AQH production
- s; increase lipolysis, thermogenesis and bladder relaxation
14
Q
G-protein linked second messengers parasympathetic
- M1
- M2
- M3
A
- q; mediates higher cog functions and stimulates enteric nervous system
- i; decrease heart rate and contractility of atria
- q; increase exocrine gland secretions, increase gut peristalsis, increase bladder contraction, bronchoconstriction
15
Q
G-protein linked second messengers dopamine
- D1
- D2
A
- s; relaxes renal vascular SM, activated direct pathway of striation
- i; modulates transmitter release, especially in brain